eXCELL Biotherapeutics Inc.

eXCELL Biotherapeutics is a regenerative medicine cell therapy company. We envision that “All cancers can be healed without causing suffering”. Thus, our mission is to provide safe, effective, affordable, and constructive anti-cancer xenogeneic cell drugs for human and pet health. The eXCELL team is comprised of leading scientists and physician who are dedicated to realizing the potential of cellular medicines to constructively restore and revive the body functions and reverse the courses of cancer progression, delivering the impactful therapies to change the patient outcomes. eXCELL is a leading biotechnology specialized in immunotherapy company developing transformative therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company’s immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell and B cell) immune systems to create long-term “immunological memory.” through the built-in rejection immune response to non-self cells. eXCELL is an immunotherapy company that uses the body built-in immune rejection responses to non-self cells to combat the difficult-to-treat cancers by utilizing xenogeneic cells that could promote cancer immunity cycle due to the similarities between xenogeneic cells and tumor cells.